2024-11-18 08:27:36
Jiangsu Recbio Technology Co., Ltd. Increases Production For The First Phase Of Manufacturing Facility With A Maximum Annual Output Of 20 Million Doses Of Recombinant HPV 9-Valent Vaccine
Corporate/ 2023-07-24
Jiangsu Recbio Technology Co., Ltd. Incr...

TAIZHOU,China,Nov. 21,2022-- (the "Company",together with its subsidiaries,the "Group") on voluntary basis. The board of...

Standigm Synthetic Research Center successfully accelerates drug discovery in its first year
Health/ 2023-07-22
Standigm Synthetic Research Center succe...

Lab uniquely enables collaboration between chemical and AI researchers SEOUL,South Korea,Nov. 17,2022--Standigm,the workflow AI-driven drug ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release